Novartis AG Registered Shares

Novartis AG Registered Shares is the common equity of Novartis AG, a global pharmaceutical company headquartered in Basel, Switzerland. The shares represent ownership in a business focused on innovative medicines across major therapeutic areas, including oncology, immunology, cardiovascular, renal and metabolic diseases, neuroscience, and ophthalmology. Novartis develops and commercializes prescription treatments that serve hospitals, specialty clinics, physicians, and patients worldwide, with an emphasis on advanced therapies, branded pharmaceuticals, and specialty care. The company also works in radioligand therapy and gene therapies, supporting targeted treatment approaches within modern healthcare systems. Novartis AG Registered Shares are used by investors seeking exposure to a diversified healthcare franchise with operations spanning research, manufacturing, and commercial distribution in key global markets.